BRCA1 mutations in southern England

British Journal of Cancer

Volumn 77, Issue 12, 1998, Pages 2199-2203

  Eccles, D M ^a   Englefield, P ^a   Soulby, M A ^a   Campbell, I G ^a  

^a PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

BRCA1; Breast cancer; Mutation analysis; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0031776827     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.366     Document Type: Article

References (24)

1. Barker DF, Almeida E, Casey G, Fain PR, Liao SY, Masunaka I, Noble B, Kurosaki T and Anton-Culver H (1996) BRCA1 R84IW - a strong candidate for a common mutation with moderate phenotype. Genetic Epidemiol 13: 595-604
2. Claus EB, Risch N and Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48: 232-242
3. Couch F, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campbeau L, Ganguly A, Rebbeck TR and Weber BL (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409-1415
4. Easton D (1997) Breast cancer genes - what are the real risks? Nature Genet 16: 210-211
5. Eeles R (1996) Testing for the breast-cancer predisposition gene, BRCA1 - documenting the outcome in gene carriers is essential. Br Med J 313: 572-573
6. Eccles, DM, Marlow A, Royle GT, Collins A and Morton NE (1994) Genetic epidemiology of early onset breast cancer. J Med Genet 31: 944-949
7. Ford D, Easton D and Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 51: 1457-1462
8. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR and Ponder B (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Gene 11: 428-433
9. Healy B (1997) BRCA genes - bookmaking, fortunetelling, and medical care. New Engl J Med 336: 1448-1449
10. Iselius L, Slack J, Littler M and Morton NE (1992) Transmission of breast cancer: a controversy resolved. Clin Genet 41: 211-217
11. Johannsson O, Ostermeyer EA, Hakansson S, Friedman LS, Johansson U, Sellberg G, Brondum-Nielson K, Sele V, Olsson H, King M and Borg A (1996) Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am J Hum Genet 58: 441-450
12. Langston AA, Malone KE, Thompson JD, Daling J and Ostrander EA (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 334: 137-142
13. Miki Y, Swensen J, Shattuck-Eidens D, Futreal FA, Harshman K, Tavtigian S, Lui Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugenstrano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannonalbright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1944) A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
14. Peelan T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AMW, Hogervorst F, Brohet R, Ligtenberg MJL, Teugels E, Van der Luijt R, Van der Hout AH, Gille JJP, Pals G, Dedema I, Olmer R, Van Leeuwen I, Newman B, Plandsoen M, Van der Est M, Brink G, Hageman S, Arts PJW, Bakker MM, Willems HW, Van der Looij E, Neyns B, Bonduelle M, Jansen R, Obsterwijk JC, Sijmons R, Smeets HJM, Van Asperen CJ, MeijersHeijoboer H, Kliju JCG, De Greve J, King MC, Menko FH, Brunner HG, Halley D, Van Ommen GJB, Vasen HFA, Cornelisse CJ, Vant Veer LJ, De Knijff P, Bakker F, and Deville P (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60: 1041-1049
15. Rebbeck TR, Couch F, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE and Weber BL (1997) Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59: 547-553
16. Richards CS, Ward PA, Roa BB, Friedman LS, Boyd AA, Kuenzli G, Dunn JK and Plon SE (1997) Screening for 185delAG in the Ashkenazim. Am J Hum Genet 60: 1085-1098
17. Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL and King M (1997) BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 60: 1031-1040
18. Serova O, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar DE, Narod SA, Lynch HT and Lenoir G (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes. Am J Hum Genet 60: 486-495
19. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, Fourquet A, Salmon RJ, Clough KB, Pouillart P, Institute Curie Breast Cancer Group, Bonaiti-Pellie C and Thomas G (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 60: 1021-1030
20. Struewing J, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS and Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11: 198-200
21. Struewing J, Tarone RE, Brody L, Li FP and Boice JD (1996) BRCA1 mutations in young women with breast cancer. Lancet 347: 1493
22. Struewing J, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody L and Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 amongst Ashkenazi Jews. New Engl J Med 336: 1401-1408
23. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H and Eyfjord JE (1997) Study of a single BRCA2 mutation and high carrier frequency in a small population. Am J Hum Genet 60: 1079-1084
24. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792